Omeros OMER
NASDAQ OMER
$16.26 -0.29 (-1.75%)
At close: Oct 21, 2026 · 4:00 PM EDT

Omeros (OMER) Capital Leases (2017 - 2018)

Updated

Omeros (OMER) posted Capital Leases of $1.58 million for Q4 2018, up 94.8% from $810,000 a year earlier.

Analysis

Omeros (OMER) Capital Leases (2017 - 2018) Analysis & Trends

  • In prior years, Omeros' Capital Leases was $810,000 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Omeros 1.17 Bn 731.45 Mn 27.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 1.58 Mn
Dec 31, 2017 810,000.00
API Access

Omeros Capital Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-leases&ticker=OMER&period=max&api_key=YOUR_API_KEY